IR@PKUHSC  > 北京大学第三临床医学院  > 药剂科
学科主题临床医学
Development and validation of a sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma
Xiong, Xin1,2; Yang, Li1; Duan, Jingli1
关键词LC-MS/MS Quetiapine Norquetiapine Human plasma
刊名CLINICA CHIMICA ACTA
2013-08-23
DOI10.1016/j.cca.2013.04.016
423页:69-74
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medical Laboratory Technology
研究领域[WOS]Medical Laboratory Technology
关键词[WOS]PERFORMANCE LIQUID-CHROMATOGRAPHY ; MASS-SPECTROMETRY ; DOUBLE-BLIND ; ACUTE SCHIZOPHRENIA ; BIPOLAR MANIA ; PLACEBO ; HPLC ; PHARMACOKINETICS ; TOLERABILITY ; MONOTHERAPY
英文摘要

Background: Quetiapine is an atypical antipsychotic agent for the treatment of schizophrenia, acute mania, and acute bipolar depression. The antidepressive response is considered to be mediated by the metabolite norquetiapine (N-desalkylquetiapine), and the aim of this study was to develop an LC-MS/MS method to measure concentrations of these compounds in human plasma.

Methods: Following one step liquid-liquid extraction, the analytes were separated using an isocratic mobile phase on a Sunfire C18 column (50 mm x 2.1 mm, 5 pm). The retention times were 2.12, 224, 2.12 and 2.19 mm for quetiapine, norquetiapine and their respective stable labeled internal standards, respectively. Cycle time was 4 min.Selected reaction monitoring (SRM) in positive ion mode was used for quantitation. Results: The present method exhibited a linear dynamic range of 0.5-500 ng/ml for quetiapine and 0.6-600 ng/ml for norquetiapine. The applicable range was extended by dilution up to 5-fold with blank matrix. The accuracy and precision for quetiapine were <103.0% and 8.8%, for norquetiapine were <108.8% and 11.1%, respectively.

Conclusions: A rapid, sensitive, and robust LC-MS/MS method for quantifying quetiapine and its metabolite norquetiapine levels in human plasma was validated and successfully applied to samples from schizophrenic patients in clinical pharmacokinetics studies. (C) 2013 Elsevier B.V. All rights reserved.

语种英语
WOS记录号WOS:000320976100015
引用统计
被引频次:9[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67967
专题北京大学第三临床医学院_药剂科
作者单位1.Peking Univ, Dept Pharm, Hosp 3, Beijing 100191, Peoples R China
2.Peking Univ, Therapeut Drug Monitoring & Clin Toxicol Ctr, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Xiong, Xin,Yang, Li,Duan, Jingli. Development and validation of a sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma[J]. CLINICA CHIMICA ACTA,2013,423:69-74.
APA Xiong, Xin,Yang, Li,&Duan, Jingli.(2013).Development and validation of a sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma.CLINICA CHIMICA ACTA,423,69-74.
MLA Xiong, Xin,et al."Development and validation of a sensitive and robust LC-MS/MS with electrospray ionization method for simultaneous quantitation of quetiapine and its active metabolite norquetiapine in human plasma".CLINICA CHIMICA ACTA 423(2013):69-74.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xiong, Xin]的文章
[Yang, Li]的文章
[Duan, Jingli]的文章
百度学术
百度学术中相似的文章
[Xiong, Xin]的文章
[Yang, Li]的文章
[Duan, Jingli]的文章
必应学术
必应学术中相似的文章
[Xiong, Xin]的文章
[Yang, Li]的文章
[Duan, Jingli]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。